38082 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 24
00:32 UTC
|
PATH
UiPath
|
◎ Target | Matthew Hedberg ★★★★★ #162 | Sec→ r Perform | $17.00→ $15.00-11.8% |
|
Sep 24
00:32 UTC
|
PATH
UiPath
|
◎ Target | Terry Tillman ★★★★★ #219 | Hold | $17.00→ $14.00-17.6% |
|
Sep 24
00:32 UTC
|
ONON
ON
|
◎ Target | Tom Nikic ★★★★☆ #801 | Buy | $37.00→ $40.00+8.1% |
|
Sep 24
00:32 UTC
|
NWG
NatWest Group
|
◎ Target | firm only | Buy | GBX 840→ GBX 860+2.4% |
|
Sep 24
00:32 UTC
|
NOC
Northrop Grumman
|
◎ Target | Douglas Harned ★★★☆☆ #2253 | Market Perform | $653.00→ $620.00-5.1% |
|
Sep 24
00:32 UTC
|
NKTR
Nektar Therapeutics
|
◎ Target | Martin Fan ★★★☆☆ #1776 | Neutral | $80.00→ $50.00-37.5% |
|
Sep 24
00:32 UTC
|
MU
Micron Technology
|
◎ Target | Atif Malik ★★★☆☆ #1526 | Buy | $1,150.00→ $1,300.00+13.0% |
|
Sep 24
00:32 UTC
|
MU
Micron Technology
|
◎ Target | Aaron Rakers ★★★★☆ #678 | Overweight | $1,525.00→ $1,400.00-8.2% |
|
Sep 24
00:32 UTC
|
MTB
M&T Bank
|
◎ Target | Brian Foran ★★★★☆ #667 | Hold | $268.00→ $250.00-6.7% |
|
Sep 24
00:32 UTC
|
MNO
Meridian Mining UK Societas
|
◎ Target | firm only | Buy | C$3.25→ C$4.00+23.1% |
|
Sep 24
00:32 UTC
|
MNO
Meridian Mining UK Societas
|
◎ Target | firm only | Outperform | C$2.75→ C$3.00+9.1% |
|
Sep 24
00:32 UTC
|
META
Meta Platforms
|
◎ Target | Deepak Mathivanan ★★★☆☆ #2001 | Overweight | $680.00→ $860.00+26.5% |
|
Sep 24
00:32 UTC
|
META
Meta Platforms
|
◎ Target | Justin Patterson ★★★☆☆ #1551 | Overweight | $780.00→ $900.00+15.4% |
|
Sep 24
00:32 UTC
|
LHX
L3Harris Technologies
|
◎ Target | Douglas Harned ★★★☆☆ #2253 | Outperform | $365.00→ $346.00-5.2% |
|
Sep 24
00:32 UTC
|
LGND
Ligand Pharmaceuticals
|
◎ Target | Yigal Nochomovitz ★★☆☆☆ #2792 | Buy | $390.00→ $397.00+1.8% |
|
Sep 24
00:32 UTC
|
KNX
Knight-Swift Transportation
|
◎ Target | Ken Hoexter ★★★☆☆ #1467 | Buy | $98.00→ $92.00-6.1% |
|
Sep 24
00:32 UTC
|
KMX
CarMax
|
◎ Target | Daniela Haigian ★★★☆☆ #1171 | Cautious | $44.00→ $47.00+6.8% |
|
Sep 24
00:32 UTC
|
KMX
CarMax
|
◎ Target | Daniela Haigian ★★★☆☆ #1171 | Equal Weight | $44.00→ $47.00+6.8% |
|
Sep 24
00:32 UTC
|
KLC
KinderCare Learning Companies
|
◎ Target | Toni Kaplan ★★★★☆ #549 | Underweight | $2.50→ $2.00-20.0% |
|
Sep 24
00:32 UTC
|
KGF
Kingfisher
|
◎ Target | firm only | Hold | GBX 295→ GBX 320+8.5% |
|
Sep 24
00:32 UTC
|
KEY
KeyCorp
|
◎ Target | Brian Foran ★★★★☆ #667 | Hold | $24.00→ $23.00-4.2% |
|
Sep 24
00:32 UTC
|
KBH
KB Home
|
◎ Target | Mike Dahl not yet tracked | Sec→ r Perform | $53.00→ $50.00-5.7% |
|
Sep 24
00:32 UTC
|
KBH
KB Home
|
◎ Target | Jonathan Bettenhausen ★★★☆☆ #1656 | Hold | $55.00→ $50.00-9.1% |
|
Sep 24
00:32 UTC
|
KBH
KB Home
|
◎ Target | Rafe Jadrosich ★★☆☆☆ #2327 | Neutral | $56.00→ $54.00-3.6% |
|
Sep 24
00:32 UTC
|
KBH
KB Home
|
◎ Target | Matthew Bouley ★★★☆☆ #1302 | Overweight | $57.00→ $49.00-14.0% |
|
Sep 24
00:32 UTC
|
KBH
KB Home
|
◎ Target | James McCanless not yet tracked | Market Outperform | $77.00→ $70.00-9.1% |
|
Sep 24
00:32 UTC
|
IP
International Paper
|
◎ Target | Detlef Winckelmann ★★★☆☆ #1005 | Overweight | $61.00→ $62.00+1.6% |
|
Sep 24
00:32 UTC
|
HSBA
HSBC
|
◎ Target | firm only | Neutral | GBX 1,570→ GBX 1,640+4.5% |
|
Sep 24
00:32 UTC
|
HII
Huntington Ingalls Industries
|
◎ Target | Douglas Harned ★★★☆☆ #2253 | Market Perform | $341.00→ $327.00-4.1% |
|
Sep 24
00:32 UTC
|
HBAN
Huntington Bancshares
|
◎ Target | Brian Foran ★★★★☆ #667 | Buy | $20.00→ $19.00-5.0% |
|
Sep 24
00:32 UTC
|
HAS
Hays
|
◎ Target | firm only | Neutral | GBX 33→ GBX 65+97.0% |
|
Sep 24
00:32 UTC
|
GTE
Gran Tierra Energy
|
◎ Target | firm only | C$17.50→ C$18.50+5.7% | |
|
Sep 24
00:32 UTC
|
GS
The Goldman Sachs Group
|
◎ Target | Benjamin Gerlinger not yet tracked | Neutral | $1,200.00→ $1,050.00-12.5% |
|
Sep 24
00:32 UTC
|
GD
General Dynamics
|
◎ Target | Douglas Harned ★★★☆☆ #2253 | Market Perform | $421.00→ $407.00-3.3% |
|
Sep 24
00:32 UTC
|
FSLY
Fastly
|
◎ Target | Rudy Kessinger ★★★★★ #58 | Neutral | $21.00→ $23.00+9.5% |
|
Sep 24
00:32 UTC
|
FSLY
Fastly
|
◎ Target | Almas Almaganbetov ★★★☆☆ #1798 | Buy | $32.00→ $37.00+15.6% |
|
Sep 24
00:32 UTC
|
FSLY
Fastly
|
◎ Target | Tal Liani ★★★★★ #291 | Underperform | $20.00→ $22.00+10.0% |
|
Sep 24
00:32 UTC
|
FITB
Fifth Third Bancorp
|
◎ Target | Brian Foran ★★★★☆ #667 | Buy | $64.00→ $63.00-1.6% |
|
Sep 24
00:32 UTC
|
FDR
Founders Metals
|
◎ Target | firm only | C$8.00→ C$9.00+12.5% | |
|
Sep 24
00:32 UTC
|
ERO
Ero Copper
|
◎ Target | firm only | C$52.00→ C$56.00+7.7% | |
|
Sep 24
00:32 UTC
|
EQT
EQT
|
◎ Target | Scott Gruber ★★★☆☆ #1203 | Buy | $67.00→ $68.00+1.5% |
|
Sep 24
00:32 UTC
|
ELE
Elemental Altus Royalties
|
◎ Target | firm only | Outperform | C$33.00→ C$36.00+9.1% |
|
Sep 24
00:32 UTC
|
ELE
Elemental Altus Royalties
|
◎ Target | firm only | C$30.00→ C$36.00+20.0% | |
|
Sep 24
00:32 UTC
|
DPZ
Domino's Pizza
|
◎ Target | Gregory Francfort ★★☆☆☆ #2536 | Neutral | $440.00→ $325.00-26.1% |
|
Sep 24
00:32 UTC
|
CNR
Canadian National Railway
|
◎ Target | firm only | Sec→ r Perform | C$192.00→ C$190.00-1.0% |
|
Sep 24
00:32 UTC
|
CNI
Canadian National Railway
|
◎ Target | Ken Hoexter ★★★☆☆ #1467 | Buy | $146.00→ $143.00-2.1% |
|
Sep 24
00:32 UTC
|
CMPX
Compass Therapeutics
|
◎ Target | Michael Schmidt ★★☆☆☆ #2413 | Buy | $4.00 |
|
Sep 24
00:32 UTC
|
CMPX
Compass Therapeutics
|
◎ Target | Reni J. Benjamin not yet tracked | Market Outperform | $4.00 |
|
Sep 24
00:32 UTC
|
CMI
Cummins
|
◎ Target | Tami Zakaria ★★★☆☆ #1326 | Neutral | $690.00→ $600.00-13.0% |
|
Sep 24
00:32 UTC
|
CLDX
Celldex Therapeutics
|
◎ Target | Judah Frommer ★★★☆☆ #1437 | Overweight | $50.00→ $57.00+14.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.